期刊文献+

多西他赛联合顺铂治疗乳腺癌的护理 被引量:2

下载PDF
导出
摘要 乳腺癌是女性最常见的恶性肿瘤之一。仅次于子宫颈癌,在我国占全身各种恶性肿瘤的7%-10%.呈逐年上升趋势。一般在40-60岁之间,绝经期前后的发病率较多。其原因不明,疑与雄雌激素的改变和紊乱右密切关系。另外与遗传、生育、哺乳、高脂肪饮食有关。随着生活水平的提高,营养过剩,肥胖可加强或延长雌激素对乳腺上皮细胞的刺激,从而增加了发病的机会。我科自2011年开始对转移性乳腺癌的患者采用多西他赛联合顺铂化疗,配合精心的护理,取得了一定的疗效。现将护理体会报告如下。
作者 王丹
机构地区 河北省承德市第
出处 《药物与人》 2014年第02S期80-80,共1页 Medicine & People
  • 相关文献

同被引文献33

  • 1Shan M, Wang X, Sun G, et al. A retrospective study of the clinical differences of Uygur breast cancer patients compared to Han breast cancer patients in the Xinjiang region of China. Int J Clin Exp Med, 2014, 7(10): 3482-3490.
  • 2Li XJ, Zha QB, Xu XY, et al. Lack of prognostic value of human epidermal growth factor-like receptor 2 status in inflammatory breast cancer (IBC): a meta-analysis. Asian Pac J Cancer Prev, 2014, 15(22): 9615-9619.
  • 3Chiba A, Shimizu S, Yoshida A, et al. Eficacy and toxicity of lapatinib plus eapecitabine therapy in HER2-positive metastatic breast cancer. Gala To Kagaku Ryoho, 2012, 39(11) : 1675-1679.
  • 4Niikura N, Saji S, Tokuda Y, et al. Brain metastases in breast cancer. Jpn J Clin Oncol, 2014, 44(12): 1133-1140.
  • 5Lam SW, de Groot SM, Honkoop AH, et al. Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a multicentre, open-label, randomised phase 2 trial. Eur J Cancer, 2014, 50(18): 3077-3088.
  • 6Sasaki T. New guidelines to evaluate the response to treatment "RECIST". Gan To Kagaku Ryoho, 2000, 27(14): 2179-2184.
  • 7Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer, 1981, 47(1): 207-214.
  • 8Niwifiska A, Murawska M, Pogoda K. Breast cancer brain metas- tases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole brain radiotherapy (WBRT). Ann Oncol, 2010, 21(5): 942-948.
  • 9Miolo G, Muraro E, Martorelli D, et al. Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploring immune proficiency in HER2+ breast cancer patients. BMC Cancer, 2014, 14(1): 954.
  • 10DE Felice F, Musio D, Cassese R, et al. Radiotherapeutic treatment approaches for brain metastases. Anticancer Res, 2014, 34(12):6913-6918.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部